Physician

Ray Page, D.O.

According to 2025 Medicare claims, Ray Page, D.O. (NPI: 1669422143) practices medical oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Parker, TX. This provider's primary affiliated billing organization is ONCOLOGY-HEMATOLOGY CONSULTANTS PA (NPI: 1629021159; TIN: 752512142) and primary practice location at 76086-5864. Page is affiliated with the SSM IL ACO, LLC (ACO ID: A4832), CoreHealth Alliance LLC (ACO ID: A5645), and UT Southwestern Accountable Care Network (ACO ID: D0211), participating under both the MSSP and REACH models.

Page's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 433 traditional Medicare patients, billed 199,113 HCPCS/CPT codes, and received $3,194,721 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,167 prescription claims across 196 beneficiaries totaling $4,610,433 in drug costs, led by Revlimid (Lenalidomide). DME data shows 80 claims. Open Payments data shows 146 records totaling $263,882. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,183,895 to $4,610,433. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $14,861 to $3,826.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	713	210,548	$2,405,881
2016	832	262,835	$3,726,861
2017	878	286,354	$3,307,580
2018	734	202,704	$3,062,326
2019	738	240,606	$3,821,496
2020	626	212,501	$3,416,251
2021	532	202,660	$3,115,044
2022	482	197,262	$2,996,767
2023	415	194,933	$2,481,968
2024	433	199,113	$3,194,721

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	160	917	$1,183,895
2016	173	1,118	$1,668,470
2017	161	1,023	$953,531
2018	147	945	$855,553
2019	165	982	$957,534
2020	174	968	$2,173,737
2021	157	779	$2,245,609
2022	173	949	$2,332,127
2023	180	945	$3,070,072
2024	196	1,167	$4,610,433

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	268	$35,277
2016	N/R	104	$6,971
2017	N/R	46	$6,299
2018	N/R	42	$1,140
2019	N/R	35	$3,741
2020	N/R	53	$3,426
2021	N/R	17	$1,869
2022	N/R	32	$1,252
2023	N/R	56	$16,584
2024	N/R	80	$4,239

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	122	360	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	285	769	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	67	85	$58
71260	Ct scan of chest with contrast	87	134	$48
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	77	211	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	39	952	$620,878
Imbruvica	Ibrutinib	40	1,144	$481,508
Erleada	Apalutamide	29	870	$432,347
Lonsurf	Trifluridine/Tipiracil Hcl	26	728	$425,940
Jakafi	Ruxolitinib Phosphate	22	660	$368,771

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	14	$2,731
J8700	Temozolomide, oral, 5 mg	N	N/R	18	$574
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$436
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$285
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	18	$213

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$2,928	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	30	$260,954	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ray Page, D.O.?

Tedicare shows public-source Medicare data for Ray Page, D.O. (NPI 1669422143), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ray Page, D.O. have ACO affiliation data?

Ray Page, D.O. is shown with ACO affiliation data for SSM IL ACO, LLC (MSSP, ACO ID A4832), CoreHealth Alliance LLC (MSSP, ACO ID A5645), and UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Ray Page, D.O.?

Ray Page, D.O. is linked to ONCOLOGY-HEMATOLOGY CONSULTANTS PA (billing NPI 1629021159) in the available physician profile data.

Does Ray Page, D.O. have Open Payments data?

Ray Page, D.O. has 146 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.